You just read:

Scottish Medicines Consortium Accepts Amgen's Multiple Myeloma Treatment, KYPROLIS® ▼ (carfilzomib), in Combination with Dexamethasone, for use at First Relapse

News provided by

Amgen

08 Aug, 2017, 07:00 BST